541 - 552 of 7683 results
1 CME CREDIT

In the United States, approximately 4 in 10 adults are using some form of complementary and alternative medicine treatment (CAM). While scientific evidence exists on some of these therapies, for many there are key questions that have yet to be answered in well-designed scientific studies. Through patient cases, this talk will explore the data behind some of the most common CAM therapies.


1 CME CREDIT

The history of cannabis (marijuana) use goes back over 5,000 years. It has been used throughout the world and increased/decreased in popular use at various times throughout the centuries. In the U.S., cannabis has been used for recreational, mood-altering experiences and for various medical conditions, such as chronic pain and epilepsy. This presentation will review the biochemical properties of cannabis as well as its mode of action and metabolism. The faculty will review the clinical studies that either support or debunk the use of medical marijuana, describe the frequency of addiction, and the present the newest work on treating withdrawal symptoms. They will also discuss the current state of legalization at the local, state, and federal level


1 CME CREDIT

Learn best practices to assess shoulder pain in this live demonstration session. A thorough physical exam and initial history is crucial to diagnose and manage shoulder injuries. The faculty will take you through best practices for evaluating rotator cuff impingement, rotator cuff tears, and frozen shoulder as well as techniques for shoulder injection.


0.5 CME CREDIT

The opioid epidemic has gripped the nation and shows no signs of slowing down. While the primary driver of opioid deaths is fentanyl, the opioid epidemic started from an increase in opioid prescriptions in the 1990s. The government and healthcare agencies have a number of proposals and initiatives centered around the 2016 CDC guidelines regarding opioid therapy to decrease the availability of prescription opioids. Despite the national climate regarding opioid use and the concerted push to decrease opioid consumption, many patients continue to push providers for opioid prescriptions to treat chronic pain. There are multiple risk mitigation strategies that can help providers identify non-compliant patients and decrease the risk of harm. Providers are encouraged to wean patients down or off opioids and promote non-opioid pharmacotherapy and multidisciplinary therapies.


1 CME CREDIT

In an increasingly litigious era of medicine, it becomes easy to over-test, over-treat, and generally over-do some basic urgent issues in the outpatient setting. This course will review some of the most common urgent outpatient complaints and evidence-based diagnostics and therapeutics that can let both you and your patient rest well without breaking the bank. We will focus on pearls for high-value care and reinforce the importance of thorough history-taking and physical exams, as they are the most valuable and least expensive tools in the clinician’s toolkit. After this review of evidence-based criteria that will allow you to proceed confidently when further management is indicated, you can reassure your patients that more isn’t always better.


0.5 CME CREDIT

Join this lecture for an overview of the pathophysiology, evaluation, and management of patients with nonalcoholic fatty liver disease. The faculty will review current concepts, disease progression, and therapeutics. You will learn about surgical treatments and their impact in patients with nonalcoholic steatohepatitis and obesity as well as the risk for hepatocellular carcinoma.


1 CME CREDIT

Information reaches clinicians at a fast and furious pace. This session will help you keep up with a review of some recent literature that impacts the health of women and other individuals. During this session, the faculty will discuss recent findings on the following topics: hormonal therapy and cancer risk, the role of testosterone in women’s health, HPV immunizations and rates of cervical cancer, and prevention strategies for breast cancer, including chemo prophylaxis for high risk individuals, guidelines for BRCA screening, and comparison of various mammography recommendations. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on February 7, 2020 and they are subject to change as new information is published.


1 CME CREDIT

e-Cigarettes were 1st introduced to the US market in 2007, essentially to help smokers stop smoking tobacco-based cigarettes. There is some evidence that, for some adults, it may be beneficial to assist with smoking cessation. However, the use of e-Cigarettes and vaping (referred to as ENDS – electronic nicotine delivery systems), has increased significantly, specifically in the US teen population. The FDA and AAP have addressed the concerns surrounding e-Cigarettes and vaping in both regulations and policy statements. Join us as we discuss the latest evidence, potential benefits, and public health concerns regarding e-Cigarettes and vaping. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on February 7, 2020 and they are subject to change as new information is published.


1 CME CREDIT

e-Cigarettes were 1st introduced to the US market in 2007, essentially to help smokers stop smoking tobacco-based cigarettes. There is some evidence that, for some adults, it may be beneficial to assist with smoking cessation. However, the use of e-Cigarettes and vaping (referred to as ENDS – electronic nicotine delivery systems), has increased significantly, specifically in the US teen population. The FDA and AAP have addressed the concerns surrounding e-Cigarettes and vaping in both regulations and policy statements. Join us as we discuss the latest evidence, potential benefits, and public health concerns regarding e-Cigarettes and vaping.


0.5 CME CREDIT

This talk will provide an evidence-based approach to the detection, treatment, and monitoring of osteoporosis. Important, recently published studies will be referenced. You will walk away more informed about controversies on how long to treat and current estimates of the rates of adverse effects of therapy.